RECITALSSettlement Agreement • February 9th, 2000 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
EXHIBIT 10.17 REAADS MEDICAL PRODUCTS, INC. -------------------------------------- STOCK PURCHASE AGREEMENT -------------------------------------- SEPTEMBER 1, 1993 STOCK PURCHASE AGREEMENT THIS AGREEMENT is entered into as of the 1st day of...Stock Purchase Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Colorado
EXHIBIT 10.6 DISTRIBUTION AGREEMENTDistribution Agreement • June 29th, 1998 • Corgenix Medical Corp/Co
OFFICE LEASEOffice Lease • June 29th, 1998 • Corgenix Medical Corp/Co
by and betweenAmendment Agreement • June 29th, 1998 • Corgenix Medical Corp/Co
EXHIBIT 10.22 CONSULTING AGREEMENT THIS AGREEMENT ("Agreement") is made and entered into this 22nd day of May, 1998 by and between TransGlobal Financial Corporation ("TGF"), a Florida corporation having a place of business at 14255 U.S. Highway 1,...Consulting Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Florida
EXHIBIT 10.10 THIS GUARANTEE is made the 1 day of November 1997 BETWEEN (1) WILLIAM GEORGE FLEMMING of The Old Rectory Holme Cambridgeshire and DOUGLASS SIMPSON care of Reaads Medical Products Inc. 20161 Tejon Street Westminster Colorado 80234 USA...Corgenix Medical Corp/Co • June 29th, 1998
RECITALSAgreement • June 29th, 1998 • Corgenix Medical Corp/Co
W I T N E S S E T HOption Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Florida
EXHIBIT 10.2 Amendment to the Manufacturing Agreement This Amendment made and entered by and between REAADS Medical Products, Inc., 12001 Tejon Street, Suite 120, Westminster, Colorado 80234, U.S.A., and ChugAI Pharmaceutical Co., Ltd., 1-9 Kyobashi...Manufacturing Agreement • June 29th, 1998 • Corgenix Medical Corp/Co
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2005 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 28, 2005, by and among CORGENIX MEDICAL CORPORATION, a Nevada corporation (the “Company”), and TRUK OPPORTUNITY FUND, LLC (“Truk Opportunity”), TRUK INTERNATIONAL FUND, LP (“Truk International”), and CAMOFI MASTER LDC (“CAMOFI”) (Truk Opportunity, Truk International, and CAMOFI each a “Purchaser” and together the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2005 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • New York
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of the 28th day of December, 2005 by and among Corgenix Medical Corporation, a corporation organized and existing under the laws of the State of Nevada (“CONX” or the “Company”), and Barron Partners L.P., a Delaware limited partnership (hereinafter referred to as the “Investor”). Unless defined otherwise, capitalized terms herein shall have the identical meaning as in the Preferred Stock Purchase Agreement.
INDEMNITY AGREEMENTIndemnity Agreement • September 24th, 1998 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
AMENDMENT TO THE DISTRIBUTION AGREEMENT BY AND BETWEEN CHUGAI PHARMACEUTICAL CO., LTD. AND REAADS MEDICAL PRODUCTS, INC. DATED SEPTEMBER 27, 1993 Chugai Pharmaceutical Co., Ltd. ("Chugai") and REAADS Medical Products, Inc. ("RMP") hereby mutually...The Distribution Agreement • June 29th, 1998 • Corgenix Medical Corp/Co
RECITALSDistribution Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Colorado
ContractCorgenix Medical Corp/Co • December 30th, 2005 • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO CORGENIX MEDICAL CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED.
ContractCorgenix Medical Corp/Co • December 30th, 2005 • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO CORGENIX MEDICAL CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED.
MANAGEMENT AGREEMENTManagement Agreement • May 5th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
This Management Agreement (“Agreement”) is made and entered into as of May 1, 2010 between Corgenix Medical Corporation, a Nevada corporation (the “Company”), and Ann L. Steinbarger (the “Executive”).
RECITALSEmployment Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Colorado
FACTORING AND SECURITY AGREEMENTFactoring and Security Agreement • March 20th, 2009 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
This Factoring and Security Agreement, dated as of March 17, 2009 is between Corgenix Medical Corporation, a Nevada corporation, which sometimes uses the name Corgenix and which sometimes uses the name Corgenix New York (collectively the “Client”) and Benefactor Funding Corp., a Colorado corporation (the “Factor”).
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • October 12th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
This Assignment and Assumption Agreement (“Agreement”) is made as of October 1, 2010, by and among Elitech UK Limited, a private limited company organized under the laws of the United Kingdom (“Assignee”), Corgenix Medical Corporation, a Nevada corporation (“Corgenix”), and Corgenix U.K. Ltd., a private limited company organized under the laws of the United Kingdom (“Corgenix U.K.” and, collectively with Corgenix, the “Assignors”).
GUARANTYGuaranty • March 19th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
This Guaranty (“Agreement”) is made and executed this day of March, 2010 by Corgenix Incorporated, a corporation, duly incorporated and validly existing pursuant to the laws of Delaware (“Guarantor”), having its principal place of business at 11575 Main Street, Broomfield, CO, in favor of FAUNUS GROUP INTERNATIONAL, INC., a Delaware corporation (“FGI”), having its principal place of business at 80 Broad Street, 22nd Floor, New York, New York 10004.
RECITALSEmployment Agreement • June 29th, 1998 • Corgenix Medical Corp/Co • Colorado
MUTUAL CONFIDENTIALITY AGREEMENTMutual Confidentiality Agreement • July 16th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Colorado
This Mutual Confidentiality Agreement (this “Agreement”), dated as of July 16, 2010, is entered into by and among Financière Elitech SAS, a société par actions simplifiée organized under the laws of France (“Elitech”), Wescor, Inc., a Utah corporation (“Wescor”), Elitech UK Limited, a private limited company organized under the laws of the United Kingdom (“Elitech UK” and, collectively with Elitech and Wescor, the “Elitech Group”), Corgenix Medical Corporation, a Nevada corporation (“Corgenix”), and Corgenix U.K. Ltd., a private limited company organized under the laws of the United Kingdom (“Corgenix U.K.” and, collectively with Corgenix, the “Corgenix Group”).
AGREEMENT CONCERNING SECURED CONVERTIBLE TERM NOTESConvertible Term Note • December 11th, 2006 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
This Agreement Concerning Secured Convertible Term Notes (this “Agreement”) is entered into by and between Corgenix Medical Corporation, a Nevada Corporation (the “Company); Truk Opportunity Fund, LLC, a Delaware company (“Truk Opportunity”); Truk International Fund, LP, a Cayman Islands company (“Truk International”); and CAMOFI Master LDC, a Cayman Islands company, formerly named DCOFI Master LDC (“CAMOFI”) on the 30th day of November, 2006 (the “Effective Date”), amending certain provisions of those certain Secured Convertible Term Notes dated May 19, 2005 and December 28, 2005 (each, a “Term Note”). All capitalized terms used, but not defined herein, shall have the meanings given to them in the Term Notes.
CORGENIX MEDICAL CORPORATION SECURITIES PURCHASE AGREEMENT DECEMBER 28, 2005Securities Purchase Agreement • September 24th, 2007 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 28, 2005, by and among Corgenix Medical Corporation, a Nevada corporation (the “Company”), and Truk Opportunity Fund, LLC, a Delaware company (“Truk Opportunity”), Truk International Fund, LP, a Cayman Islands company (“Truk International”), and CAMOFI Master LDC, a Cayman Islands company, formerly named DCOFI Master LDC, (“CAMOFI”) (Truk Opportunity, Truk International and CAMOFI, each a “Purchaser” and together the “Purchasers”).
SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • June 29th, 1998 • Corgenix Medical Corp/Co
DEBENTURE (CLIENT) (including mortgage over plant, machinery and equipment)Corgenix Medical Corp/Co • March 19th, 2010 • In vitro & in vivo diagnostic substances • England and Wales
June 7, 2005 [NAME] [ADDRESS] Dear [NAME]:Corgenix Medical Corp/Co • June 24th, 2005 • In vitro & in vivo diagnostic substances
On [DATE], you loaned Corgenix Medical Corporation (the “Company”) $[ ] as evidenced by that certain promissory notes dated [DATE] (the “Promissory Notes”), a copy of which is attached to this letter agreement. You and the Company have agreed in principal to a transaction whereby the Company would issue shares of the Company’s common stock (“Shares”) and warrants to acquire additional shares of common stock (“Warrants”) in exchange for your agreement to accept the Shares and Warrants in full satisfaction of all amounts owed by the Company to you pursuant to the terms of the Promissory Note. This letter memorializes the agreement between you and the Company and sets forth the specific terms and conditions thereof:
LOAN AND SECURITY AGREEMENT Between SUMMIT FINANCIAL RESOURCES, L.P. Lender and CORGENIX MEDICAL CORPORATION CORGENIX, INC. Borrower Effective Date: September 30, 2009Loan and Security Agreement • October 6th, 2009 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Utah
This Loan and Security Agreement is made and entered into by and between Summit Financial Resources, L.P., CORGENIX MEDICAL CORPORATION, and CORGENIX, INC.
REVOLVING CREDIT AND SECURITY AGREEMENT between CORGENIX MEDICAL CORPORATION “Borrower” and LSQ FUNDING GROUP, L.C. “Lender” Dated: , 2011Revolving Credit and Security Agreement • July 20th, 2011 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Florida
THIS AGREEMENT (the “Agreement”) is made as of , 2011 by and between Corgenix Medical Corporation, a Nevada corporation (“Borrower”), and LSQ Funding Group, L.C., a Florida limited liability company (“Lender”).
SECOND AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT AND WARRANTCommon Stock Purchase Agreement and Warrant • September 1st, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
Corgenix Medical Corporation, a Nevada corporation (the “Company”), and Medical & Biological Laboratories Co., Ltd., a corporation organized under the laws of Japan (the “Purchaser”), hereby amend certain provisions of the Common Stock Purchase Agreement dated as of July 1, 2002 and the Common Stock Purchase Warrant dated as of July 3, 2002, each by and between the Company and the Purchaser (the “Purchase Agreement”), as of the 15th day of July, 2008 (this “Second Amendment”).
VOTING AGREEMENTVoting Agreement • August 28th, 2014 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Delaware
This VOTING AGREEMENT (this “Agreement”) is entered into as of August 27, 2014 by and among Centennial Medical Holdings, Inc. (“Parent”), and the shareholders of Corgenix Medical Corporation, a Nevada corporation (the “Company”) listed on Schedule A hereto (each, a “Shareholder” and collectively, the “Shareholders”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).
THIRD AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT AND WARRANTCommon Stock Purchase Agreement and Warrant • September 1st, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances
Corgenix Medical Corporation, a Nevada corporation (the “Company”), and Medical & Biological Laboratories Co., Ltd., a corporation organized under the laws of Japan (the “Purchaser”), hereby amend, as of the first day of August, 2010 (this “Third Amendment”), certain provisions of the Common Stock Purchase Agreement dated as of July 1, 2002 and the Common Stock Purchase Warrant dated as of July 3, 2002, each by and between the Company and the Purchaser (the “Purchase Agreement”).
COMMON STOCK PURCHASE AGREEMENT by and among CORGENIX MEDICAL CORPORATION FINANCIÈRE ELITECH SAS AND WESCOR, INC. July 12, 2010Common Stock Purchase Agreement • July 16th, 2010 • Corgenix Medical Corp/Co • In vitro & in vivo diagnostic substances • Nevada
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into effective as of July 12, 2010 (the “Effective Date”), by and among Corgenix Medical Corporation, a Nevada corporation (the “Company”), Financière Elitech SAS, a société par actions simplifiée organized under the laws of France (“Elitech”), and Wescor, Inc., a Utah corporation and subsidiary of Elitech (“Investor”).
